Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1055 of 5804
-
Could a simple procedure replace hysterectomy for heavy bleeding?
Disease control Recruiting nowThe present study aims to compare the efficacy (menstrual blood loss, pain, quality of life) and the safety (complications, recovery) of each conservative intervention (RFA, UAE) versus hysterectomy for the treatment of adenomyosis-related abnormal uterine bleeding, up to 2 years
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New device aims to reduce heart transplant complications
Disease control Recruiting nowThe goal of this clinical trial is to test the feasibility of the study protocol comparing a novel temperature control system - Xo Port Organ Preservation System - to static ice for heat preservation for Heart Transplant. The main questions of the study are as follows: Does the …
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New weekly shot could transform diabetes care
Disease control Recruiting nowThis study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when compared to placebo or semaglutide. The purpose of this clinical study is to find out if NNC0662-0419 is effective and safe for treating people …
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat lung cancers in early trial
Disease control Recruiting nowThis study is an open-label first-in-human phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX3901 in patients with Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma.
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Custom-Made cancer vaccine enters early human testing
⭐️ VACCINE ⭐️ Not yet recruitingThe purpose of this study is to evaluate the safety and tolerability of ABO2109 in combination with toripalimab, and to evaluate the immunogenicity, pharmacokinetics, pharmacodynamics, as well as biomarker characteristics of the investigational cancer vaccine. In addition, the an…
Phase: EARLY_PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:33 UTC
-
New blood test could spot hidden belly infections faster
Diagnosis Recruiting nowThe NATURAL Study is a prospective, observational, pragmatic study of RNA biomarkers of infections to aid in the diagnosis of abdominal pain. Summary of Research Study: Hypothesis: A genomic-derived panel of 6 RNA biomarkers present in stabilized whole blood will provide diagno…
Sponsor: True Bearing Diagnostics, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Genetic clues to mysterious childhood movement disorders in vietnam
Knowledge-focused Recruiting nowThis observational patient registry aims to describe the clinical phenotypes and genetic findings of Vietnamese children with movement disorders of unknown etiology. Eligible participants are children with clinically confirmed movement disorders after evaluation by pediatric neur…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Could this pill prevent Chemo-Related bleeding risks?
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
App aims to unlock words after stroke
Symptom relief Recruiting nowThis study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language train…
Phase: NA • Sponsor: Nunaps Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New study tracks how a drug combo affects liver function in advanced cancer patients
Knowledge-focused Recruiting nowItalian multicenter observational study to evaluate time to clinical hepatic decompensation, quality of life, effectiveness, and safety of tremelimumab plus durvalumab in patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic treatment…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New hope for tough myeloma: experimental drug SG2918 enters human trials
Disease control Recruiting nowThe primary objective of this study was to evaluate the safety and tolerability of SG2918 in patients with relapsed/refractory multiple myeloma.
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
AI finds hidden sperm in infertile men, offering new hope for fatherhood
Knowledge-focused Recruiting nowThis study will help determine whether an AI-assisted microwell platform (IntelliWell) can identify rare sperm cells in testicular samples found to not have sperm by conventional analysis. Instead of discarding testicular tissue which was found to be non-sperm bearing by conventi…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug trial hopes to thicken skin Disease's fate
Disease control Recruiting nowA Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Phase: PHASE2 • Sponsor: Mediar Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New Low-Cost HPV test could save lives in poor countries
Diagnosis Recruiting nowIn high-income countries, prevention strategies have led to declines in cervical cancer rates by more than 75% in high-income countries. In contrast, low- and middle-income countries (LMICs) carry the global burden of cervical cancer with about 85% of new cases and 90% mortality.…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New hope for Crohn's? Real-World study tests IL-23 drugs
Disease control Recruiting nowThe goal of this observational study is to learn about the effectiveness and safety of IL-23 inhibitors in adults with active Crohn's disease in real-world clinical practice. The main questions it aims to answer are: * What proportion of participants achieve clinical remission a…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Higher dose hormone therapy aims to control rare calcium disorder
Disease control Recruiting nowThis trial has a duration of 78 weeks and will include adult participants already on treatment with palopegteriparatide at doses at or greater than 30 mcg/day. All participants will receive subcutaneous palopegteriparatide during the trial and will be individually and progressive…
Phase: PHASE3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Stem cell patch aims to slow vision loss in rare eye disease
Disease control Recruiting nowThe Goal of this study is to evaluate the safety, tolerability, and clinical responses following single dose of DSP-3077. Study enrolls both male and female patients in 3 cohorts with each cohort defined by visual acuity (VA) criteria and dose level of DSP-3077. Each cohort will …
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a simple CT scan save heart bypass patients from future attacks?
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate whether a coronary computed tomography angiography (CTCA)-guided strategy can reduce the risk of death, heart attack, stroke, and hospital admissions in patients experiencing angina or myocardial infarction following coronary artery …
Phase: NA • Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy aims to hit MS early and hard
Disease control Not yet recruitingThe HiHat trial is a Phase 2 study aimed at evaluating the safety and feasibility of sequential treatment with rituximab and cladribine in patients with relapsing-remitting multiple sclerosis (RRMS). The study follows a prospective, open-label, single-arm design, with 60 RRMS pat…
Phase: PHASE2 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for stubborn low platelets after transplant?
Disease control Not yet recruitingThis is a prospective, open-label phase 1b/2 clinical trial to explore the safety and efficacy profiles of baricitinib in patients with thrombopoietin-receptor-agonist-refractory persistent thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC